You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Delpazolid

Showing 1 - 12 of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nontuberculous Mycobacterium Infection, Mycobacterium Abscessus Infection Trial (Delpazolid)

Not yet recruiting
  • Nontuberculous Mycobacterium Infection
  • Mycobacterium Abscessus Infection
  • Delpazolid
  • (no location specified)
Aug 21, 2023

MRSA Bacteremia Trial in Gwangju, Seoul (Delpazolid, Vancomycin, Placebo of Delpazolid)

Recruiting
  • MRSA Bacteremia
  • Delpazolid
  • +2 more
  • Gwangju, Korea, Republic of
  • +2 more
Jan 25, 2023

Infections and Infestations, Pulmonary Tuberculosis Trial in South Africa, Tanzania (Delpazolid, Bedaquiline, Delamanid,

Active, not recruiting
  • Infections and Infestations
  • Pulmonary Tuberculosis
  • Delpazolid
  • Bedaquiline, Delamanid, Moxifloxacin
  • Tembisa, Gauteng, South Africa
  • +4 more
Sep 13, 2022

Healthy Trial in Seongnam-si (LCB01-0371 tablet 400mg (Test drug, Batch# 3183817R), LCB01-0371 tablet 400mg (Reference drug,

Completed
  • Healthy
  • LCB01-0371 tablet 400mg (Test drug, Batch# 3183817R)
  • LCB01-0371 tablet 400mg (Reference drug, Batch# 1650006)
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
    Seoul National University Bundang Hospital
Jun 17, 2021

Healthy Trial in Seoul (LCB01-0371 dose with a [14C]-LCB01-0371-tracer dose)

Completed
  • Healthy
  • LCB01-0371 dose with a [14C]-LCB01-0371-tracer dose
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 10, 2021

Pulmonary Tuberculosis Trial in Seoul (LCB01-0371 800mg, QD, LCB01-0371 400mg, BID, LCB01-0371 800mg, BID)

Completed
  • Pulmonary Tuberculosis
  • LCB01-0371 800mg, QD
  • +5 more
  • Seoul, Korea, Republic of
    Asan Medical Center
Feb 4, 2020

Healthy Trial in Seoul (LCB01-0371, LCB01-0371 400mg)

Completed
  • Healthy
  • Seoul, Korea, Republic of
    Bae KS
Apr 9, 2018

Healthy Trial in Seoul (Group 1:LCB01-0371, Group 2:LCB01-0371)

Terminated
  • Healthy
  • Group 1:LCB01-0371
  • Group 2:LCB01-0371
  • Seoul, Korea, Republic of
    Asan Medical Center
Apr 7, 2016

Healthy Trial in Bundang (LCB01-0371 Tablet 800 mg(R), LCB01-0371 Tablet 800 mg(T))

Completed
  • Healthy
  • LCB01-0371 Tablet 800 mg(R)
  • LCB01-0371 Tablet 800 mg(T)
  • Bundang, Gyeonggi, Korea, Republic of
    Seoul National University Bundang Hospital
Mar 22, 2016

Healthy Trial in Bundang (LCB01-0371 800mg, LCB01-0371 800mg BID, LCB01-0371 1200mg BID)

Completed
  • Healthy
  • LCB01-0371 800mg
  • +3 more
  • Bundang, Gyeonggi, Korea, Republic of
    Seoul National University Bundang Hospital
Sep 1, 2015

Healthy Trial in Seoul (LCB01-0371 800mg, LCB01-0371 1200mg, Placebo)

Completed
  • Healthy
  • LCB01-0371 800mg
  • +2 more
  • Seoul, Korea, Republic of
    Asan Medical Center
Nov 14, 2014

Healthy Trial in Seoul, (LCB01-0371, Linezolid)

Completed
  • Healthy
  • Seoul,, Korea, Republic of
    Asan Medical Center
Nov 13, 2014